Clinical Trial: The Purpose of This Study is to Evaluate the Safety, Tolerability and Efficacy of TMT101 Injection Monotherapy in Patients with Advanced Pancreatic Cancer or Non-small Cell Lung Cancer(NSCLC)

U.S., March 7 -- ClinicalTrials.gov registry received information related to the study (NCT06861543) titled 'The Purpose of This Study is to Evaluate the Safety, Tolerability and Efficacy of TMT101 Injection Monotherapy in Patients with Advanced Pancreatic Cancer or Non-small Cell Lung Cancer(NSCLC)' on Feb. 08.

Brief Summary: This is a first-in-human, single-arm, open-label, dose escalation prospective phase I clinical study to evaluate the Safety, Tolerability and Efficacy of TMT101 Injection Alone in patients with Unresectable, Metastatic or Advanced pancreatic cancer or Non-small Cell Lung Cancer(NSCLC) after Standard Treatment Failure. The primary objective is to evaluate the safety and tolerability of TMT101 Injection as monotherapy ...